PT1558610E - Compostos substituídos de aminoquinuclidina e sua utilização como ligandos do receptor delta-opióide - Google Patents

Compostos substituídos de aminoquinuclidina e sua utilização como ligandos do receptor delta-opióide Download PDF

Info

Publication number
PT1558610E
PT1558610E PT03776299T PT03776299T PT1558610E PT 1558610 E PT1558610 E PT 1558610E PT 03776299 T PT03776299 T PT 03776299T PT 03776299 T PT03776299 T PT 03776299T PT 1558610 E PT1558610 E PT 1558610E
Authority
PT
Portugal
Prior art keywords
delta
opioid receptor
agents
receptor ligands
useful
Prior art date
Application number
PT03776299T
Other languages
English (en)
Inventor
Robert E Boyd
Allen B Reitz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT1558610E publication Critical patent/PT1558610E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
PT03776299T 2002-10-15 2003-10-14 Compostos substituídos de aminoquinuclidina e sua utilização como ligandos do receptor delta-opióide PT1558610E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41860302P 2002-10-15 2002-10-15

Publications (1)

Publication Number Publication Date
PT1558610E true PT1558610E (pt) 2008-04-18

Family

ID=32107953

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03776299T PT1558610E (pt) 2002-10-15 2003-10-14 Compostos substituídos de aminoquinuclidina e sua utilização como ligandos do receptor delta-opióide

Country Status (13)

Country Link
US (1) US7179818B2 (pt)
EP (1) EP1558610B1 (pt)
JP (1) JP2006504754A (pt)
AT (1) ATE387443T1 (pt)
AU (1) AU2003284068A1 (pt)
CA (1) CA2501552A1 (pt)
CY (1) CY1107928T1 (pt)
DE (1) DE60319405T2 (pt)
DK (1) DK1558610T3 (pt)
ES (1) ES2300626T3 (pt)
PT (1) PT1558610E (pt)
SI (1) SI1558610T1 (pt)
WO (1) WO2004035574A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638560A1 (en) 2003-06-20 2006-03-29 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
CN100549004C (zh) 2003-10-01 2009-10-14 阿得罗公司 螺环杂环衍生物及其应用方法
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049676B1 (en) * 1997-12-24 2005-10-12 Ortho-Mcneil Pharmaceutical, Inc. 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
EP1242421A1 (en) 1999-12-22 2002-09-25 Ortho-McNeil Pharmaceutical, Inc. 4-[aryl(8-azabicyclo[3.2.1] octan-3-yl)] aminobenzoic acid derivatives

Also Published As

Publication number Publication date
CY1107928T1 (el) 2013-09-04
SI1558610T1 (sl) 2008-08-31
US7179818B2 (en) 2007-02-20
DE60319405D1 (de) 2008-04-10
AU2003284068A8 (en) 2004-05-04
AU2003284068A1 (en) 2004-05-04
EP1558610B1 (en) 2008-02-27
ES2300626T3 (es) 2008-06-16
CA2501552A1 (en) 2004-04-29
WO2004035574A2 (en) 2004-04-29
DK1558610T3 (da) 2008-06-23
EP1558610A2 (en) 2005-08-03
DE60319405T2 (de) 2009-02-26
WO2004035574A8 (en) 2004-07-29
US20040110789A1 (en) 2004-06-10
WO2004035574A3 (en) 2004-06-03
ATE387443T1 (de) 2008-03-15
JP2006504754A (ja) 2006-02-09

Similar Documents

Publication Publication Date Title
WO2001066543A3 (en) 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
HK1071890A1 (en) Spiroazacyclic compounds as monoamine receptor modulators
MXPA06001647A (es) 6-(2, 2, 2-trifluoroetilamino) -7-cloro-2, 3, 4, 5-tetrahidro- 1h-benzo[d] azepina como un agonista del receptor 5-ht2c.
MY144483A (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
IL148071A0 (en) Method for treatment of symptoms of central nervous system disorders
TW200504034A (en) Therapeutic agents
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
GB0329498D0 (en) Organic compounds
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
NO20015413D0 (no) Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser
MXPA04003087A (es) Derivados de cromano como ligados de 5-hidroxitriptamina-6.
MY124786A (en) Bis-arylsulfones
PL372179A1 (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
MXPA06000701A (es) Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.
UA72948C2 (uk) Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
GB9815618D0 (en) Treatment of dyskinesia
TW200607802A (en) 3-piperidinylisochroman-5-ols as dopamine agonists
PT730865E (pt) Utilizacao de bloqueadores dos receptores de serotonina e dopamina para o tratamento de perturbacoes mentais associadas a doencas cerebrovasculares
CY1107928T1 (el) Ενωσεις υποκατεστημενης αμινοκινουκλιδινης και χρησις των ως συνδεσμικα μεσα δελτα-οπιοειδους υποδοχεως
PT1642576E (pt) Utilização de derivados de pirrole para combate da ansiedade
GB9924941D0 (en) Treatment of dyskinesia
MXPA06000700A (es) Compuestos de sulfonildihidroimidazopiridinona como ligandos de 5-hidroxitriptamina-6.
TWI245756B (en) Improved process for the preparation of 1,3-substituted indenes
BR0308911A (pt) Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto